A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)

NCT06741228 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

214

Enrollment

INDUSTRY

Sponsor class

Conditions

Generalized Anxiety Disorder

Interventions

OTHER: Placebo
DRUG: MM120 (LSD D-Tartrate)

Sponsor

Definium Therapeutics US, Inc.